Insights into brown spider and loxoscelism

Invertebrate Survival Journal

Volumn 2, Issue 2, 2005, Pages 152-158

  Appel, M H ^a   da Silveira, R Bertoni ^a,c   Gremski, W ^a,b   Veiga, Silvio S ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brown spider; Dermonecrosis; Loxoscelism; Recombinant toxins; Venom

Indexed keywords

EID: 38549098973     PISSN: None     EISSN: 1824307X     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Andrade RMG, Oliveira KC, Giusti AL, Silva WD, Tambourgi DV. Ontogenetic development of Loxosceles intermedia spider venom. Toxicon 37: 627-632, 1999.
2. Andrade RMG, Lourenço WR, Tambourgi DV. Comparison of the fertility between Loxosceles intermedia and Loxosceles laeta spiders. J. Arachnol. 28: 245-247, 2000.
3. Atkin JA, Wingo CW, Sodeman WA, Flynn JE. Necrotic arachnidism. Am. J. Trop. Med. 7: 165-184, 1958.
4. Barbaro KC, Eickstedt VRD, Mota I. Antigenic cross-reactivity of venoms from medically important Loxosceles (Araneae) species in Brazil. Toxicon 32: 113-120, 1994.
5. Barbaro KC, Ferreira ML, Cardoso DF, Eickstedt VRD, Mota I. Identification and neutralization of biological activities in venoms of Loxosceles spiders. Braz. J. Med. Biol. Res. 29: 1491-1497, 1996a.
6. Barbaro KC, Souza MV, Morhy L, Eickstedt VRD, Mota I. Compared chemical properties of dermonecrotic and lethal toxins from spiders of genus Loxosceles (Araneae). J. Protein Chem. 15: 337-343, 1996b.
7. Barbaro KC, Ferreira ML, Cardoso DF, Souza MV, Morhy L, Eickstedt VRD, Mota I. Study of Loxosceles spider venom. J. Ven. Anim. Toxins 3: 232, 1997.
8. Barbaro KC, Knysak I, Martins R, Hogan C, Winkel K. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas. Toxicon 45: 489-499, 2005.
9. Borkkan J, Gross E, Lubin Y, Oryan I. An outbreak of venomous spider bites in a citrus grove. Am. J. Trop. Med. Hyg. 52: 228-230, 1995.
10. Chaim OM, Sade YB, da Silveira RB, Toma L, Kalapothakis E, Cháves-Olórtegui C, Mangili OC, Gremski W, Dietrich CP, Nader HB, Veiga SS. Brown spider dermonecrotic toxin directly induces nephrotoxicity. Toxicol. App. Pharmacol. 2006 (in press).
11. Cohen N, Sarafian DA, Alon I, Gorelik O, Zaidenstein R Simantov R, Blatt A, Litinsky I, Modai D, Golik A. Dermonecrotic loxoscelism in the Mediterranean region. J. Toxicol. Cut. Ocul. Toxicol. 18: 75-83, 1999.
12. Cunha RB, Barbaro KC, Muramatsu D, Portaro FCV, Fontes W, Sousa MV. Purification and characterization of Loxnecrogin, a dermonecrotic toxin from Loxosceles gaucho brown spider venom. J. Prot. Chem. 22: 135- 146, 2003.
13. da Silva PH, Hashimoto Y, Santos FA, Mangili OC, Gremski W, Veiga SS. Hematological cell findings in bone marrow and peripheral blood of rabbits after experimental acute exposure to Loxosceles intermedia (brown spider) venom. Toxicon 42: 155-161, 2003.
14. da Silva PH, da Silveira RB, Appel MH, Mangili OC, Gremski W, Veiga SS. Brown spider and loxoscelism. Toxicon 44: 693-709, 2004.
15. da Silveira RB, Filho JFS, Mangili OC, Veiga SS, Gremski W, Nader HB, Dietrich CP. Identification of proteases in the extract of venom glands from brown spiders. Toxicon 40: 815-822, 2002.
16. Desai A, Miller, MJ, Gomez HF, Warren JS, Loxosceles deserta spider venom induces NF-sB-dependent chemokine production by endothelial cells. Clin. Toxicol. 37: 447-456, 1999.
17. Desai A, Lankford HA, Warren JS. Loxosceles deserta spider venom induces the expression of vascular endothelial growth factor (VEGF) in keratinocytes. Inflammation 24: 1-9, 2000.
18. Elston DM, Eggers JS, Schmidt WE, Storrow AB, Doe RH, McGlasson D, Fischer JR. Histological findings after brown recluse spider envenomation. Am. J. Dermatopathol. 22: 242-246, 2000.
19. Escoubas P, Diochot S, Corzo G. Structure and pharmacology of spider venom neurotoxins. Biochimie 82: 893-907, 2000.
20. Feitosa L, Gremski W, Veiga SS, Elias MCQB, Graner E, Mangili OC, Brentani RR. Detection and characterization of metalloproteinases with gelatinolytic, fibronectinolytic and fibrinogenolytic activities in brown spider (Loxosceles intermedia) venom. Toxicon 36: 1039-1051, 1998.
21. Futrell J. Loxocelism. Am. J. Med. Sci. 304: 261-267, 1992.
22. Goddard J. Loxoscelism. N. Engl. J. Med. 339: 1944-1945, 1998.
23. Gomez HF, Miller MJ, Desai A, Warren JS. Loxosceles spider venom induces the production of alpha and beta chemokines: implications for the pathogenesis of dermonecrotic arachnidism. Inflammation 23: 207-2015, 1999.
24. Guilherme P, Fernandes I, Barbaro KC. Neutralization of dermonecrotic and lethal activities and differences among 32-35kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies. Toxicon 39: 1333-1342, 2001.
25. Hogan C, Barbaro KC, Winkel K. Loxoscelism: old obstacles, new directions. Ann. Emerg. Med. 44: 608-624, 2004.
26. Isbister Gk, Graudins A, White J, Warrell D. Antivenom treatment in arachnidism. J. Toxicol. Clin. Toxicol. 41: 291-300, 2003.
27. Isbister GK. Necrotic arachnidism: the mythology of a modern plague. Lancet 364: 549-553, 2004.
28. Isbister GK, Vetter RS. Loxoscelism and necrotic arachnidism: More myths and minor corrections. Ann. Emerg. Med. 46: 205-206, 2005.
29. Kalapothakis E, Araujo SC, Castro CS, Mendes TM, Gomez MV, Mangili OC, Gubert IC, Chavez-Olórtegui C. Molecular cloning, expression and immunological properties of LiD1, a protein from the dermonecrotic family of Loxosceles intermedia spider venom. Toxicon 40: 1691-1699, 2002
30. Lee S, Lynch KR. Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA). Biochem. J. 391: 317-323, 2005.
31. Luciano MN, Silva PH, Chaim OM, Santos VL, Franco CRC, Soares MFS, Zanata SM, Mangili OC, Gremski W, Veiga SS. Experimental evidence for a direct cytotoxicity of Loxosceles intermedia (brown spider) venom on renal tissue. J. Histochem. Cytochem. 52: 455-467, 2004.
32. Macchiavello A. Cutaneous arachnidism or gangrenous spot of Chile. Pub. Health Trop. Med. 22: 425-466, 1947.
33. Málaque CMS, Ori M, Santos SA, Andrade DR. Production of TNF-ooby primary cultures of human keratinocytes challenged with Loxosceles gaucho venom. Rev. Inst. Med. Trop. S. Paulo, 41, 1999.
34. Málaque CMS, Castro-Valencia JE, Cardoso JLC, França FOS, Bárbaro KC, Fan HW. Clinical and epidemiological features of definitive and presumed loxoscelism in São Paulo, Brazil. Rev. Inst. Med. Trop. S. Paulo, 44, 2002.
35. McGlasson DL, Babcock JL, Berg L, Triplett DA. ARACHnase. An evaluation of a positive control for platelet neutralization procedure testing with seven commercial activated partial thromboplastin time reagents. Am. J. Pathol. 100: 576-578, 1993.
36. Merigian KS, Blaho R. Envenomation from brown recluse spider: review of mechanism and treatment options. Am. J. Ther. 10: 724-734, 1996.
37. Monteiro CLB, Rubel R, Cogo LL, Mangili OC, Gremski W Veiga SS. Isolation and identification of Clostridium perfringens in the venom and fangs of Loxosceles intermedia (brown spider): enhancement of the dermonecrotic lesion in loxoscelism. Toxicon 40: 409- 418, 2002.
38. Mota I, Barbaro KC. Biological and biochemical properties of venom from medically important Loxosceles (Araneae) species in Brazil. J. Toxicol. Tox. Rev. 14: 401-421, 1995.
39. Nicholson GM, Graudins A. Antivenoms for treatment of spider envenomation. J. Toxicol. Tox. Rev. 22: 35-59, 2003.
40. Nishioka SA. Misdiagnosis of brown recluse spider bite. West. J. Med. 174: 240, 2001.
41. Oliveira KC, Andrade RMG, Giusti AL, Silva WD, Tambourgi DV. Sex-linked variation of Loxosceles intermedia spider venoms. Toxicon 37: 217-221, 1999.
42. Oliveira KC, Andrade RMG, Piazza RMF, Ferreira JMC, van den Berg CW, Tambourgi DV. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation. Toxicon 45: 421-429, 2005.
43. Ospedal KZ, Appel MH, Neto JF, Mangili OC, Veiga SS, Gremski W. Histopathological findings in rabbits after experimental acute exposure to the Loxosceles intermedia (brown spider) venom. Int. J. Exp. Pathol. 84: 287-294, 2002.
44. Patel KD, Modur V, Zimmerman GA. The necrotic venom of the brown recluse spider induces dysregulated endothelial cell-dependent neutrophil activation: differential induction of GM-CSF, IL-8, and E-selectin expression. J. Clin. Invest. 94: 631-642, 1994.
45. Pedrosa MFF, Azevedo ILMJ, Andrade RMG, Berg CW, Ramos CRR, Ho PL, Tambourgi DV. Molecular cloning and expression of functional dermonecrotic and haemolytic factor from Loxosceles laeta venom. Biochem. Bioph. Res. Commun. 298: 638-645, 2002.
46. Ramos-Cerrillo B, Olvera A, Odell GV, Zamudio F, Paniagua- Solis J, Alagón A, Stock RP. Genetic and enzymatic characterization of sphingomyelinase D isoforms from the North American fiddleback spiders Loxosceles boneti and Loxosceles recluse. Toxicon 44: 507-514, 2004.
47. Roodt AR, Salomon, OD, Lloveras SC, Orduna TA. Poisoning by spiders of Loxosceles genus. Medicina 62: 83-94, 2002.
48. Rash LD, Hodgson WC. Pharmacology and biochemistry of spider venoms. Toxicon 40: 225-254, 2002.
49. Sams HH, Dunnick CA, Smith ML, King LE. Necrotic arachnidism. J. Am. Acad. Dermatol. 44: 561-537, 2001.
50. Sandidge JS. Arachnology: scavenging by brown recluse spiders. Nature 426: 30, 2003
51. Schenone H. Diagnosis in 1348 patients which consulted for a probable spider bite or insect sting. Bol. Chil. Parasitol. 51: 20-27, 1996.
52. Schienle A, Schäfer A Walter B, Stark R, Vaitl D. Brain activation of spider phobics towards disorder-relevant, generally disgust- and fear-inducing pictures. Neurosci. Lett. 388: 1-6, 2005.
53. Sezerino UM, Zannin M, Coelho LK, Gonçalves J, Grando M, Mattosinho SG, Cardoso JLC, Eickstedt VR, França FOS, Bárbaro KC, Fan HW. A clinical and epidemiological study of Loxosceles spider envenoming in Santa Catarina, Brazil. Trans. R. Soc. Trop. Med. Hyg. 92: 546-548, 1998.
54. Sunderkötter C, Seeliger S, Schönlau F, Roth J, Hallmann R, Luger TA, Sorg C, Kolde G. Different pathway leading to cutaneous leukocytoclastic vasculitis in mice. Exp. Dermatol. 10: 391-404, 2001.
55. Tambourgi DV, Magnoli FC, Eickstedt VRD, Benedetti ZC, Petricevich VL, Silva WD. Incorporation of 35kDa purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway. J. Immunol. 155: 4459-4466, 1995.
56. Tambourgi DV, Petricevich VL, Magnoli FC, Assaf SLMR, Mancar S, Silva WD. Endotoxemic-like shock induced by Loxosceles spider venoms: pathological changes and putative mediators. Toxicon 36: 391-403, 1998.
57. Veiga SS Gremski W, Santos VLP, Feitosa L, Mangili OC, Nader HB, Dietrich CP, Brentani RR. Oligosaccharide residues of Loxosceles intermedia (brown spider) venom proteins: dependence on glycosylation for dermonecrotic activity. Toxicon 37: 587-607 1999.
58. Veiga SS, Feitosa L. Santos VLP, Souza GA, Ribeiro AS, Mangili OC, Porcionatto MA, Nader HB, Dietrich CP, Brentani RR, Gremski W. Effect of brown spider venom on basement membrane structures. Histochem. J. 32: 397-408, 2000a.
59. Veiga SS, da Silveira RB, Dreyfuss JL, Haoach J, Pereira AM, Mangili OC, Gremski W. Identification of high molecular weight serine-proteases in Loxosceles intermedia (brown spider) venom. Toxicon 38: 825-839, 2000b.
60. Veiga SS, Zanetti VC, Franco CRC, Trindade ES, Porcionatto MA, Mangili OC, Gremski W, Dietrich CP, Nader HB. In vivo and in vitro cytotoxicity of brown spider venom for blood vessel endothelial cells. Throm. Res. 102: 229-237, 2001a.
61. Veiga SS, Zaneti VC, Braz A, Mangili OC, Gremski W. Extracellular matrix molecules as target for brown spider venom toxins. Braz. J. Med. Biol. Res. 34: 843-850, 2001b.
62. Vetter RS. Identifying and misidentifying the brown recluse spider. Dermatol. Online J. 5: 7, 1999.
63. Vetter RS, Barger DK. An infestation of 2, 055 brown recluse spiders (Araneae:Sicariidae) and no envenomation in a Kansas home: implications for bite diagnoses in nonendemic areas. J. Med. Entomol. 39: 948-951, 2002.
64. Vetter RS, Bush SP. Reports of presumptive brown recluse spider reinforce improbable diagnosis in region of North America where the spider is not endemic. Clin. Inf. Dis. 35: 442-445, 2002a.
65. Vetter RS, Bush SP. The diagnosis of brown recluse spider bite is overused for dermonecrotic wounds of uncertain etiology. Ann. Emerg. Med. 39: 544-546, 2002b.
66. Vetter RS, Cushing PE, Crawford RL, Royce LA. Diagnoses of brown recluse spider bites (loxoscelism) greatly outnumber actual verifications of spider in four western American states. Toxicon 42: 413-418, 2003.
67. Vetter RS, Visscher PK. Bites and stings of medically important venomous arthopods. Int. J. Dermatol. 37: 481-496, 1998.
68. Wendell RP. Brown recluse spiders: a review to help guide physicians in nonendemic areas. South. Med. J. 96: 486-490, 2003.
69. Wright SW, Wrenn KD, Murray L, Seger D. Clinical presentation and outcome of brown spider bite. Ann. Emerg. Med. 30: 28-32, 1997.
70. Yannias JA, Winkelmann RK. Persistent painful plaque due to a brown recluse spider bite. Cutis 50: 273-275, 1992.
71. Young AR, Pincus SJ. Comparison of enzymatic activity from three species of necrotising arachnids in Australia: Loxosceles rufescens, Badumma insignis and Lampona cylindrata. Toxicon 39: 391-400, 2001.
72. Zanetti VC, da Silveira RB, Dreyfuss JL, Haoach J, Mangili OC, Veiga SS, Gremski W. Morphological and biochemical evidence of blood vessel damage and fibrinogenolysis triggered by brown spider venom. Blood Coag. Fibrin. 13: 135-148, 2002.